NOW RECRUITING: Patients with Pulmonary Arterial Hypertension (PAH) for IMPAHCT,
a Phase 2b/3 study evaluating AV-101. Learn more about the study.

Sue Fischer

Sue has more than 20 years of experience in clinical operations in both academic and pharmaceutical industry settings. She previously built and led high functioning clinical operations teams at EMD Serono, Acetylon Pharmaceuticals and Syndax Pharmaceuticals. Prior to that, Sue spent six years supporting clinical research at Massachusetts General Hospital and Dana-Farber/Harvard Cancer Center.  Sue’s expertise includes delivery of clinical trials across all phases of development in multiple therapeutic areas, team and people development, large scale vendor oversight, contracting and management, GCP and inspection readiness.